Moreover, although Erastin treatment decreased tumor size, the overexpression of SPINK4 also significantly promoted tumor size in the presence of Erastin (Fig. 5A-C), suggesting that the overexpression of SPINK4 blocked Erastin-induced ferroptosis in vivo. The gene discussed is SPINK4; the disease is neoplasm.